0000000000052079

AUTHOR

Guillaume Lezmi

0000-0001-7742-5523

showing 2 related works from this author

Associations of black carbon with lung function and airway inflammation in schoolchildren

2019

Background: Few studies have investigated the 24-hour respiratory health effects of personal black carbon (BC) and ultrafine particles (UFP) exposure in schoolchildren. The objective of this study was to investigate these associations with the lung function in children 10-years old with and without persistent respiratory symptoms. Methods: We conducted a cross-sectional study in 305 children (147 and 158 with and without persistent respiratory symptoms, respectively) from three European birth-cohorts: PARIS (France) and INMA Sabadell and Valencia (Spain). Personal 24-hour measurements of exposure concentrations to BC and UFP were performed by portable devices, before lung function testing. …

MaleVital capacity010504 meteorology & atmospheric sciencesVital Capacity010501 environmental sciences[SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract01 natural sciencesLung function parameters (FVC and FEV1)Forced Expiratory VolumeRespiratory systemChildLunglcsh:Environmental sciencesLung functionGeneral Environmental Sciencelcsh:GE1-350Airway inflammationrespiratory systemRespiratory Function Tests3. Good healthChild PreschoolBreathingFemaleFrancemedicine.medical_specialtyLung function parameters (FVC and FEV(1))SchoolchildrenNitric OxideFEV1/FVC ratioBlack carbonExposure concentrationsSootInternal medicineLung function parameters (FVC and FEV1medicineHumansFeNOBronchitis0105 earth and related environmental sciencesInflammation[SDV.EE.SANT]Life Sciences [q-bio]/Ecology environment/Health[SDV.MHEP.PED]Life Sciences [q-bio]/Human health and pathology/Pediatricsbusiness.industryInfant NewbornInfantConfidence intervalrespiratory tract diseasesCross-Sectional Studies) FeNOUltrafine particlesSpainExhaled nitric oxideParticulate Matter[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologiebusiness
researchProduct

Pleuroparenchymal fibroelastosis as a late complication of chemotherapy agents

2014

To the Editor: We identified six patients with clinical, radiographic and physiological features typical of pleuroparenchymal fibroelastosis (PPFE). In the six cases, PPFE may have been causally related to prior alkylating drugs used to treat malignacy, namely cyclophosphamide in five of the cases and carmustine (BCNU (1,3-bis-(2-chloroethyl)-1-nitrosourea)) in one. Based on an extensive review of the literature, we suspect that similar cases may have already been reported in the past 4 decades but have not been recognised either as PPFE or as drug-induced in nature. In 2004, Frankel et al. [1] described a then-new clinicopathologic entity, which they termed “idiopathic PPFE”. The authors i…

Pulmonary and Respiratory MedicineChemotherapyPathologymedicine.medical_specialtyLungCyclophosphamidebusiness.industrymedicine.medical_treatmentmedicine.diseasemedicine.anatomical_structureFibrosisParenchymaEtiologyMedicinebusinessIdiopathic interstitial pneumoniaPathologicalmedicine.drugEuropean Respiratory Journal
researchProduct